Lacosamide Tablets, USP, C V, 100mg, Rx only, 60-count bottle
Recalled by Annora Pharma Private Limited
Class II — moderate
Using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.
Annora Pharma Private Limited has recalled Lacosamide Tablets, USP, C V, 100mg, Rx only, 60-count bottle, according to data published by the U.S. Food and Drug Administration (FDA). The recall was reported on July 1, 2026 and was initiated on June 4, 2026. It is classified as a Class II recall, which means using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.
Below is a plain-English summary of what was recalled, why it was recalled, how to tell whether you have the affected product, and what steps you can take. For the complete and most current details, you can view the FDA record linked further down this page.
What was recalled?
This recall covers Lacosamide Tablets, USP, C V, 100mg, Rx only, 60-count bottle, with approximately 31,392 60-count bottles affected. The company behind the recall is Annora Pharma Private Limited, based in Hyderabad, N/A. The FDA describes the product as: “Lacosamide Tablets, USP, C V, 100mg, Rx only, 60-count bottle, By: Annora Pharma Pvt., Ltd, Sangareddy -502313, Telangana, India, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, NDC 31722-813-60.”
Why was Lacosamide Tablets, USP, C V, 100mg, Rx only, 60-count bottle recalled?
According to the FDA, the stated reason for the recall is: “Presence of a Foreign Tablets: Complaint received, possible mix-up of Selexipag 1000 mcg tablet in a bottle of Lacosamide Tablets USP, 100mg.”
What should you do?
If you think you may have bought Lacosamide Tablets, USP, C V, 100mg, Rx only, 60-count bottle, compare it against the product description and identifying codes (Lot: A253999, A254000, Expires: 09/30/2027.) before using it. This recall is currently listed as ongoing.
The general guidance for a matching product is to stop using it and follow the instructions in the official FDA recall notice, which may include a repair, replacement, refund, or safe disposal. When in doubt, contact Annora Pharma Private Limited or your local health authority.
About this recall
This recall was distributed in N/A. RecallRadar summarizes recall information from public FDA data to make it easier to understand. We are an independent service and are not affiliated with the FDA or any government agency, so please always refer to the official source for the authoritative record — and note the “last synced” date shown on this page, since recall details can change over time.
Full recall details
- Status
- Ongoing
- Date reported
- July 1, 2026
- Recall started
- June 4, 2026
- Distributed in
- N/A
What you can do
Check whether any product you have matches the description and codes above. If it does, stop using it and follow the instructions in the official recall notice. When in doubt, contact the company or your local health authority.
Quick answers
Why was Lacosamide Tablets, USP, C V, 100mg, Rx only, 60-count bottle recalled?+
According to the FDA: Presence of a Foreign Tablets: Complaint received, possible mix-up of Selexipag 1000 mcg tablet i…
How serious is this recall?+
Class II — moderate. Using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.
What should I do if I have Lacosamide Tablets, USP, C V, 100mg, Rx only, 60-count bottle?+
Compare your product against the description and identifying codes on this page. If it matches, stop using it and follow the instructions in the official recall notice — this usually means returning it for a refund or discarding it. When in doubt, contact the company or your local health authority.
Opens the U.S. Food and Drug Administration (FDA) data for this recall.
Recall number: D-0626-2026. Information last synced from the FDA on July 11, 2026.